Psychiatry and Neurology, Neurology · Colorado Springs, CO
NPI
1609195676
Since 2010
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
5770 Flintridge Dr, Suite 100
Colorado Springs, CO, 80918
Phone (517) 353-8122
Groups this clinician bills Medicare through
Medicare paid, 2024
$376K
28,720 services
Medicare patients, 2024
552
Average age 73
Drug cost, 2024
$2.0M
3,375 prescriptions
Company payments, 2025
$36K
From 41 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Brad J Priebe was code J0585 (injection, onabotulinumtoxina, 1 unit), 25,200 times for 47 patients. In total Brad J Priebe billed 28,720 services in 45 codes, and Medicare paid $376K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-11-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 25,200 | 47 | $4.79 | $121K |
| 99214 Office E&M - Established | Office | 768 | 371 | $90.73 | $70K |
| 99215 Office E&M - Established | Office | 422 | 243 | $130.71 | $55K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 221 | 161 | $12.67 | $2,799 |
| 99426 Chronic, Principal, and Transitional Care Management | Office | 134 | 42 | $48.58 | $6,509 |
| 99427 Chronic, Principal, and Transitional Care Management | Office | 131 | 40 | $37.41 | $4,901 |
| 99205 Office E&M - New | Office | 108 | 108 | $169.54 | $18K |
| 64615 Musculoskeletal | Office | 84 | 30 | $105.46 | $8,859 |
| 99204 Office E&M - New | Office | 43 | 43 | $110.99 | $4,773 |
| 99213 Office E&M - Established | Office | 25 | 22 | $61.00 | $1,525 |
| 95886 Electrical Nerve Conductivity | Office | 20 | 14 | $75.27 | $1,505 |
| 99483 Office/Outpatient Services | Office | 20 | 19 | $206.72 | $4,134 |
| 95816 Neurologic | Office | 18 | 18 | $321.92 | $5,795 |
By year: 2022 $175K for 16,927 services; 2023 $299K for 20,373 services; 2024 $376K for 28,720 services.
Medicare prescription drug claims, 2024
In 2024, the drug Brad J Priebe prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 391 prescriptions and refills. In total Brad J Priebe wrote 3,375 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 391 | 839 | 95 | $15K |
| Donepezil Hcl Generic | 285 | 588 | 64 | $2,442 |
| Gabapentin Generic | 284 | 576 | 83 | $7,588 |
| Duloxetine Hcl Generic | 237 | 493 | 58 | $5,562 |
| Rytary Carbidopa/Levodopa | 198 | 292 | 35 | $238K |
| Memantine Hcl Generic | 116 | 257 | 29 | $3,967 |
| Levetiracetam Generic | 107 | 269 | 29 | $5,379 |
| Pregabalin Generic | 104 | 181 | 36 | $4,331 |
| Quetiapine Fumarate Generic | 95 | 135 | 20 | $1,359 |
| Lacosamide Generic | 84 | 131 | 19 | $23K |
| Fludrocortisone Acetate Generic | 80 | 116 | 13 | $1,585 |
| Primidone Generic | 73 | 158 | 20 | $1,862 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 61 | 147 | 18 | $3,808 |
| Sertraline Hcl Generic | 47 | 97 | 14 | $274 |
| Pyridostigmine Bromide Generic | 44 | 92 | 11 | $3,646 |
Brand drugs: 569 claims; generic drugs: 2,806 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Brad J Priebe $36K ($36K in general payments such as food, travel and fees) from 41 companies. The largest payer was Abbvie Inc. with $14K.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 50 | $14K |
| Lilly USA, LLC LLY | 11 | $8,901 |
| Pfizer Inc. PFE | 58 | $8,624 |
| TG Therapeutics, Inc. TGTX | 20 | $716 |
| UCB, Inc. UCB.BR | 14 | $395 |
| Novartis Pharmaceuticals Corporation NVS | 19 | $390 |
| Alexion Pharmaceuticals, Inc. AZN | 12 | $301 |
| AstraZeneca Pharmaceuticals LP AZN | 12 | $209 |
| ACADIA Pharmaceuticals Inc ACAD | 12 | $197 |
| Neurocrine BioSciences, Inc. NBIX | 6 | $156 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.